AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 400 participants.

Also called NCT07555730

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07555730
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07555730. Randomized; no masking; primary purpose treatment. Start 2026-04-30 (anticipated); primary completion 2028-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)
Condition
Overweight or Obesity; Type 2 Diabetes
Condition
Weight Loss Maintenance
Intervention (Behavioral)
AI assisted multi-domain lifestyle intervention
Intervention (Drug)
Tirzepatide
Lead sponsor
Huazhong University of Science and Technology (class: other)

Record details

Record id
cardio:ct-nct07555730
Content hash
7c810c6645d1bc2ad66fa4cd8cbfeffaa528f305c57d904524b9a96e3d6a5784